Therapeutic Giving: Oncology Grant

The Therapeutic Giving: Oncology program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatments and services, promote health equity, and strengthen healthcare workforces. It supports programs that raise disease awareness, empower patients, and improve health systems with measurable outcomes. Eligible applicants include nonprofit organizations with 501(c)(3) status, emphasizing innovative programs addressing healthcare disparities and unmet needs.

NOTE:

• Application period is January - October 15th.For event-specific funding, applications must be submitted at least sixty (60) days prior to the event.
• About Us

Janssen is interested in funding programs and initiatives that improve patient access to treatment and services, advance health equity and strengthen frontline health workforces within the therapeutic areas noted.
Our preference is in support of programs focused on health system improvement with measurable outcomes over fundraising activities.
Disease Areas
AmyloidosisLeukemia & Lymphoma: Chronic Lymphocytic Leukemia (CLL), Waldenström's Macroglobulinemia (WM), Chronic Graft-versus-host Disease (cGVHD)Lung CancerMetastatic Castration-Sensitive Prostate CancerMetastatic Castration-Resistant Prostate CancerNon-Metastatic Castration-Resistant Prostate CancerMultiple MyelomaUnresectable or metastatic liposarcoma or leiomyosarcomaUrothelial/Bladder Cancer
Areas of Interest
Education of patients and caregiversFamily/caregiver support including transportation/lodging challenges associated with treatment, psychotherapy, managing side effects of medications, wellness education, advocacy supportInnovative efforts to empower patients and their caregivers to manage the diseaseTools to assist patients and families related to therapyEfforts to build skills of professionals and caregivers to improve patient outcomesEfforts to address healthcare disparities for marginalized or at-risk groups (outreach and awareness, education to policy makers, stigma and cultural competence initiatives)Efforts to address impaired functionality, long absence or giving up work by patient and/or caregiver, and education for broader community around patient supportDirect patient services or linkage to care; disease screenings Outreach to those without access to medical care or poor accessAdvocacy initiatives on access to care to treat individual patient need

Eligibility

Only nonprofit organizations classified by the IRS as 501 (c)(3) are eligible to apply for a charitable contribution.All contribution requests are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).Applications are evaluated competitively with emphasis given to innovative programs with measurable outcomes that address disparities or areas of high unmet need.Funding decisions will consider prevalence, population served, program design, organizational capacity, and anticipated outcomes.

Ineligibility

Faxed, e-mailed and postal-mailed requests will not be considered. Some requests or categories may not meet our guidelines for giving. These exclusions include the following:Organizations that do not have a valid non-profit, tax-exempt statusLoansTrips or toursSectarian and religious organizations that do not serve the general public on a nondenominational basisCapital requests (building funds, endowments, multi-year commitments) are generally not supportedPolitical groupsAdvocacy activities directed towards specific legislationOrganizations whose missions/objectives do not meet our contributions guidelinesDonations to individuals or to a charity on behalf of a customerEducational grants for healthcare professionals; see instead our education grants program for our funding priorities in this area.Research grantsCommercial Co-Ventures (CCV)